STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...

Eli Lilly's Mounjaro has seen explosive growth since its March launch in India, with sales soaring to Rs 50 crore in three ...

The US president said he plans to implement a 50 per cent duty on US copper imports and a 200 per cent tariff on ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

Eli Lilly and Johnson & Johnson, PPH’s largest holdings, are facing unique challenges, impacting the ETF’s overall ...

Shares in drug companies such as Eli Lilly dropped from their session highs Tuesday afternoon after President Donald Trump said U.S. tariffs on imported pharmaceuticals could be as high as 200%.

President Trump said he plans to implement a 50 per cent duty on US copper imports and apply a crippling 200 per cent tariff ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...